Leukemia Clinical Research Foundation (EIN 411586846) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Principal Officer

Dr Michael Caligiuri

Phone

6123083126

Tax Period

2023-01-01 to 2023-12-31

Leukemia Clinical Research Foundation is a micro nonprofit that reported $78K in total revenue in fiscal year 2023. Expenses of $68K left a modest 12% surplus.

Mission

THE FOUNDATION'S PURPOSES IS TO ENGAGE IN, ASSIST AND CONTRIBUTE TO THE SUPPORT OF CHARITABLE, SCIENTIFIC OR EDUCATIONAL ACTIVITIES AND PROJECTS INCLUDING, BUT NOT LIMITED TO, CLINICAL RESEARCH AND THE STUDY OF ADULT LEUKEMIA AND LYMPHOMAS FOR THE PURPOSES OF FURTHERING UNDERSTANDING AND TREATMENT OF THESE DISORDERS. FOR THESE PURPOSES, THE FOUNDATION AWARDED GRANTS TOTALLING $15,000 DURING THE CURRENT YEAR

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $30,293

Program Service Revenue $0

Investment Income $47,219

Other Revenue $0

TOTAL REVENUE $77,512

Expense Breakdown

Grants Paid $15,000

Salaries & Benefits $0

Fundraising Expenses $11,307

Program Expenses $52,091

Other Expenses $53,353

TOTAL EXPENSES $68,353

Year-over-Year Comparison

	2023	2022	Change
Revenue	$77,512	N/A	N/A
Expenses	$68,353	N/A	N/A
Net Income	$9,159	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Dr Michael Caligiuri	President	1.00	Officer Director	$0	$0	$0
Kenneth D Rowe	Treasurer	20.00	Officer Director	$0	$0	$0
Dr Hartmut Doehner	Board Member	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$77,512	$68,353	$674,012	$9,159
2022	$44,306	$68,411	$693,017	$-24,105
2021	$82,701	$64,214	$783,196	$18,487
2020	$117,352	$174,120	$792,285	$-56,768
2019	$82,328	$433,729	$898,570	$-351,401
2018	$84,767	$450,269	$1,204,465	$-365,502

Leukemia Clinical Research Foundation